Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Platycladus Orientalis leaf vesicles may help treat anxiety, depression, and insomnia.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

New non-surgical treatments for hair loss show promising results with fewer side effects.

Finasteride use may increase depression and suicide risk, especially at 1 mg, so monitoring is advised.

New method measures finasteride in blood quickly and accurately.

Biologicals are increasingly used in medicine and cosmetics, especially for skin and hair treatments, but more research is needed.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

A new, simple, and accurate method was created to measure finasteride in tablets.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Psychodermatosis is reclassified based on brain-skin interaction, dividing conditions into psychogenic and psychosomatic categories.

Melatonin improved mental health and metabolism in women with PCOS.

The interdisciplinary approach improved the quality of life for a Parkinson's patient and eased staff workload.

The conclusion suggests that treatments targeting root causes of chronic diseases may be developed by focusing on gene expression and lifestyle factors.

High levels of prolactin in the blood can be linked to widespread hair loss.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Young patients using finasteride may have higher risks of anxiety, depression, and suicidal thoughts.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Psychiatric issues often appear as skin problems, affecting 30% of dermatology patients.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

New acne treatments show promise as alternatives to traditional therapies.

Finasteride may help reduce opioid use.

Hormonal therapies effectively treat acne and improve quality of life.